1-3 of 3
Sundar Neelakantan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Saman Hewamana, Suhair Alghazal, Thet Thet Lin, Matthew Clement, Chris Jenkins, Monica L. Guzman, Craig T. Jordan, Sundar Neelakantan, Peter A. Crooks, Alan K. Burnett, Guy Pratt, Chris Fegan, Clare Rowntree, Paul Brennan, Chris Pepper
Journal: Blood
Blood (2008) 111 (9): 4681–4689.
https://doi.org/10.1182/blood-2007-11-125278
Published: 2008
Journal Articles

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Monica L. Guzman, Randall M. Rossi, Sundar Neelakantan, Xiaojie Li, Cheryl A. Corbett, Duane C. Hassane, Michael W. Becker, John M. Bennett, Edmund Sullivan, Joshua L. Lachowicz, Andrew Vaughan, Christopher J. Sweeney, William Matthews, Martin Carroll, Jane L. Liesveld, Peter A. Crooks, Craig T. Jordan
Journal: Blood
Blood (2007) 110 (13): 4427–4435.
https://doi.org/10.1182/blood-2007-05-090621
Published: 2007
Includes: Supplemental data
Journal Articles

A Novel Orally Available Parthenolide Analog Selectively Eradicates AML Stem and Progenitor Cells.

Monica L. Guzman, PhD, Randall M. Rossi, MS, Xiaojie Li, BS, Cheryl Corbett, BS, Duane C. Hassane, PhD, Timothy Bushnell, PhD, Martin Carroll, MD, Edmund Sullivan, DVM, Sundar Neelakantan, PhD, Peter A. Crooks, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2006) 108 (11): 237.
https://doi.org/10.1182/blood.V108.11.237.237
Published: 2006